Skip to main content
Erschienen in: Cancer Causes & Control 1/2012

01.01.2012 | Original paper

Dual effect of short interval between first and second birth on ductal breast cancer risk in Finland

verfasst von: A. Kauppila, P. Kyyrönen, M. Lehtinen, E. Pukkala

Erschienen in: Cancer Causes & Control | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Objective

A short interval between the first and second birth was associated with an increased risk of advanced ductal breast cancer among women with 5+ childbirths in our previous study. We now evaluated the significance of this risk factor and its relation to the age at first birth among mothers with 2–4 children.

Methods

The cohort of 190,949 Finnish women with 2–4 children comprised 3,834 women with ductal breast cancer diagnosed before 2009. Conditional logistic regression for case–control design nested within the cohort was used to estimate proportional hazard ratios (HR) associated with the birth interval. Controls were matched for age and number of children. Age at the first birth and the interval from the last birth to cancer were co-variables.

Results

Among women with the first birth <30 years, the HR of advanced ductal breast cancer at 50+ years for a short (<1.5 years) versus long (>3 years) interval between the first and second birth was 0.48 (95% Confidence Interval 0.33–0.70). Among women with the first birth at 30+ years, the HR of this cancer type diagnosed before the age of 50 years for a short versus long interval between the first and second birth was 5.83 (95% CI 2.30–14.8).

Conclusion

The interval between first and second birth strongly influences the risk of ductal breast cancer. Because second pregnancy soon after the first one decreased the risk of ductal breast cancer in young primiparas but increased the risk in older primiparas, it is likely that in such circumstances second pregnancy continues the actions initiated by the first pregnancy/breast-feeding.
Literatur
1.
Zurück zum Zitat Kvåle G, Heuch I (1987) A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am J Epidemiol 126:842–850PubMed Kvåle G, Heuch I (1987) A prospective study of reproductive factors and breast cancer. II. Age at first and last birth. Am J Epidemiol 126:842–850PubMed
2.
Zurück zum Zitat Albrektsen G, Heuch I, Hansen S, Kvåle G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Brit J Cancer 92:167–175PubMedCrossRef Albrektsen G, Heuch I, Hansen S, Kvåle G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Brit J Cancer 92:167–175PubMedCrossRef
3.
Zurück zum Zitat Hinkula M, Pukkala E, Kyyrönen P, Kauppila A (2001) Grand multiparity and the risk of breast cancer: population-based study of Finland. Cancer Causes Control 12:491–500PubMedCrossRef Hinkula M, Pukkala E, Kyyrönen P, Kauppila A (2001) Grand multiparity and the risk of breast cancer: population-based study of Finland. Cancer Causes Control 12:491–500PubMedCrossRef
4.
Zurück zum Zitat Kauppila A, Kyyrönen P, Hinkula M, Pukkala E (2009) Birth intervals and breast cancer. Brit J Cancer 101:1213–1217PubMedCrossRef Kauppila A, Kyyrönen P, Hinkula M, Pukkala E (2009) Birth intervals and breast cancer. Brit J Cancer 101:1213–1217PubMedCrossRef
5.
Zurück zum Zitat Lambe M, Hsieh C–C, Trichopoulos D, Ekbom A, Pavia M, Adami H-O (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9PubMedCrossRef Lambe M, Hsieh C–C, Trichopoulos D, Ekbom A, Pavia M, Adami H-O (1994) Transient increase in the risk of breast cancer after giving birth. N Engl J Med 331:5–9PubMedCrossRef
6.
Zurück zum Zitat Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7:131–142PubMedCrossRef Russo J, Moral R, Balogh GA, Mailo D, Russo IH (2005) The protective role of pregnancy in breast cancer. Breast Cancer Res 7:131–142PubMedCrossRef
7.
Zurück zum Zitat Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151:715–722PubMed Chie WC, Hsieh C, Newcomb PA, Longnecker MP, Mittendorf R, Greenberg ER (2000) Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 151:715–722PubMed
8.
Zurück zum Zitat Wagner KU, Smith GH (2005) Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia 10:25–36PubMedCrossRef Wagner KU, Smith GH (2005) Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia 10:25–36PubMedCrossRef
9.
Zurück zum Zitat Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG, Li Y (2008) Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells - implication for pregnancy-induced protection against breast cancer. Stem Cells 26:3205–3209PubMedCrossRef Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG, Li Y (2008) Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells - implication for pregnancy-induced protection against breast cancer. Stem Cells 26:3205–3209PubMedCrossRef
10.
Zurück zum Zitat Lagiou A, Lagiou P, Vassilarou DS, Stoikidou M, Trichopoulos D (2003) Comparison of age at first full-term pregnancy between women with breast cancer and women with benign breast diseases. Int J Cancer 107:817–821PubMedCrossRef Lagiou A, Lagiou P, Vassilarou DS, Stoikidou M, Trichopoulos D (2003) Comparison of age at first full-term pregnancy between women with breast cancer and women with benign breast diseases. Int J Cancer 107:817–821PubMedCrossRef
11.
Zurück zum Zitat Russo J, Balogh GA, Russo IH, and the FCCC Hospital Network Participants (2008) Full term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17:51–66PubMedCrossRef Russo J, Balogh GA, Russo IH, and the FCCC Hospital Network Participants (2008) Full term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 17:51–66PubMedCrossRef
12.
Zurück zum Zitat Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 33:365–369PubMedCrossRef Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 33:365–369PubMedCrossRef
13.
Zurück zum Zitat Pukkala E (2011) Biobanks and registers in epidemiological research of cancer. In: Dillner J (ed) Methods in biobanking. Methods in molecular biology, vol 675. Totowa, Humana Press, pp 61–112 doi:10.1007/978-1-59745-423-03 Pukkala E (2011) Biobanks and registers in epidemiological research of cancer. In: Dillner J (ed) Methods in biobanking. Methods in molecular biology, vol 675. Totowa, Humana Press, pp 61–112 doi:10.​1007/​978-1-59745-423-03
14.
Zurück zum Zitat Hemminki K, Försti A, Sundquist J, Ji J (2008) Risk of familial breast cancer is not increased after pregnancy. Breast Cancer Res Treat 108:417–420PubMedCrossRef Hemminki K, Försti A, Sundquist J, Ji J (2008) Risk of familial breast cancer is not increased after pregnancy. Breast Cancer Res Treat 108:417–420PubMedCrossRef
15.
Zurück zum Zitat Mac Mahon B, Cole P, Lin M et al (1970) Age at first birth and breast cancer risk. Bull WHO 43:209–221 Mac Mahon B, Cole P, Lin M et al (1970) Age at first birth and breast cancer risk. Bull WHO 43:209–221
16.
Zurück zum Zitat Kelsey J, Gammon MD, John EM (1993) Reproductive and hormonal risk factors. Reproductive factors and breast cancer. Epidemiol Rev 15:36–46PubMed Kelsey J, Gammon MD, John EM (1993) Reproductive and hormonal risk factors. Reproductive factors and breast cancer. Epidemiol Rev 15:36–46PubMed
17.
Zurück zum Zitat Merrill RM, Fugal S, Novilla LB, Raphael MC (2005) Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 96:583–593PubMedCrossRef Merrill RM, Fugal S, Novilla LB, Raphael MC (2005) Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 96:583–593PubMedCrossRef
18.
Zurück zum Zitat Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurses’ Health Study. Am J Epidemiol 152:950–964PubMedCrossRef Colditz GA, Rosner B (2000) Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurses’ Health Study. Am J Epidemiol 152:950–964PubMedCrossRef
19.
Zurück zum Zitat Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270–282PubMedCrossRef Yager JD, Davidson NE (2006) Estrogen carcinogenesis in breast cancer. N Engl J Med 354:270–282PubMedCrossRef
20.
Zurück zum Zitat Bernstein L, Lipworth L, Ross R, Trichopoulos D (1995) Correlation of oestrogen levels between successive pregnancies. Am J Epidemiol 142:625–628PubMed Bernstein L, Lipworth L, Ross R, Trichopoulos D (1995) Correlation of oestrogen levels between successive pregnancies. Am J Epidemiol 142:625–628PubMed
21.
Zurück zum Zitat Janssens JP, Russo J, Russo I et al (2007) Human gonadotropin (hCG) and prevention of breast cancer. Mol Cell Endocrinol 269:93–98PubMedCrossRef Janssens JP, Russo J, Russo I et al (2007) Human gonadotropin (hCG) and prevention of breast cancer. Mol Cell Endocrinol 269:93–98PubMedCrossRef
22.
Zurück zum Zitat Lukanova A, Andersson R, Wulff M et al (2008) Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol 168:1284–1291PubMedCrossRef Lukanova A, Andersson R, Wulff M et al (2008) Human chorionic gonadotropin and alpha-fetoprotein concentrations in pregnancy and maternal risk of breast cancer: a nested case-control study. Am J Epidemiol 168:1284–1291PubMedCrossRef
23.
Zurück zum Zitat Russo IH, Russo JH (2000) Hormonal approach to breast cancer protection. J Cell Biochem 77:1–6CrossRef Russo IH, Russo JH (2000) Hormonal approach to breast cancer protection. J Cell Biochem 77:1–6CrossRef
24.
Zurück zum Zitat Russo J, Hu YF, Silva IDCG, Russo IH (2001) Cancer risk related to mammary gland structure and development. Microscopy Res Technique 52:204–223CrossRef Russo J, Hu YF, Silva IDCG, Russo IH (2001) Cancer risk related to mammary gland structure and development. Microscopy Res Technique 52:204–223CrossRef
25.
Zurück zum Zitat Hsieh C-L, Pavia M, Lambe M, Lan S-J, Colditz GA, Ekbom A et al (1994) Dual effect of parity on breast cancer risk. Eur J Cancer 30A:969–973PubMedCrossRef Hsieh C-L, Pavia M, Lambe M, Lan S-J, Colditz GA, Ekbom A et al (1994) Dual effect of parity on breast cancer risk. Eur J Cancer 30A:969–973PubMedCrossRef
26.
Zurück zum Zitat Peck J, Hulka B, Poole C, Saviz D, Baird D, Richardson B (2002) Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 11:361–368PubMed Peck J, Hulka B, Poole C, Saviz D, Baird D, Richardson B (2002) Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 11:361–368PubMed
28.
Zurück zum Zitat Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M (2001) Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 153:1079–1084PubMedCrossRef Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M (2001) Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 153:1079–1084PubMedCrossRef
29.
Zurück zum Zitat Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5–73PubMedCrossRef Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2:5–73PubMedCrossRef
31.
Zurück zum Zitat Bruzzi P, Negri E, La Vecchia C et al (1988) Short term increase in risk of breast cancer after full term pregnancy. Brit Med J 297:1096–1098PubMedCrossRef Bruzzi P, Negri E, La Vecchia C et al (1988) Short term increase in risk of breast cancer after full term pregnancy. Brit Med J 297:1096–1098PubMedCrossRef
32.
Zurück zum Zitat Russo J, Russo IH (1994) Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3:353–364PubMed Russo J, Russo IH (1994) Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 3:353–364PubMed
33.
Zurück zum Zitat Byers T, Graham S, Rzepka T, Marshall J (1985) Lactation and breast cancer. Evidence for a negative association in premenopausal women. Am J Epidemiol 121:664–674PubMedCrossRef Byers T, Graham S, Rzepka T, Marshall J (1985) Lactation and breast cancer. Evidence for a negative association in premenopausal women. Am J Epidemiol 121:664–674PubMedCrossRef
34.
Zurück zum Zitat Collaborative Group of Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without this disease. Lancet 360:187–195CrossRef Collaborative Group of Hormonal Factors in Breast Cancer (2002) Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without this disease. Lancet 360:187–195CrossRef
35.
Zurück zum Zitat Ursin G, Bernstein L, Lord SJ et al (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Brit J Cancer 93:364–371PubMedCrossRef Ursin G, Bernstein L, Lord SJ et al (2005) Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Brit J Cancer 93:364–371PubMedCrossRef
36.
Zurück zum Zitat Newcomb PA, Storer PE, Longnecker MP (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330:81–87PubMedCrossRef Newcomb PA, Storer PE, Longnecker MP (1994) Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330:81–87PubMedCrossRef
37.
Zurück zum Zitat Lord SJ, Bernstein L, Johnson KA et al (2008) Breast cancer and hormone receptor status in older women by parity, age at first birth, and breastfeeding: a case control study. Cancer Epidemiol Biomarkers Prev 17:1723–1730PubMedCrossRef Lord SJ, Bernstein L, Johnson KA et al (2008) Breast cancer and hormone receptor status in older women by parity, age at first birth, and breastfeeding: a case control study. Cancer Epidemiol Biomarkers Prev 17:1723–1730PubMedCrossRef
38.
Zurück zum Zitat Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive factors, age at maximum height, and three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev 17:3427–3434PubMedCrossRef Beaber EF, Holt VL, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive factors, age at maximum height, and three histologic types of breast cancer. Cancer Epidemiol Biomarkers Prev 17:3427–3434PubMedCrossRef
39.
Zurück zum Zitat LiVolsi VA, Kelsey JL, Fisher DB et al (1982) Effect of age at first birth childbirth on risk of developing specific histologic subtype of breast cancer. Cancer 49:1937–1940PubMedCrossRef LiVolsi VA, Kelsey JL, Fisher DB et al (1982) Effect of age at first birth childbirth on risk of developing specific histologic subtype of breast cancer. Cancer 49:1937–1940PubMedCrossRef
40.
Zurück zum Zitat Wohlfarth J, Mouridsen H, Andersen PK, Melbye M (1999) Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer 81:49–55CrossRef Wohlfarth J, Mouridsen H, Andersen PK, Melbye M (1999) Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer 81:49–55CrossRef
41.
Zurück zum Zitat Dickman PW, Hakulinen T, Luostarinen T, Pukkala E et al (1999) Survival of cancer patients in Finland 1955–1994. Acta Oncol 38(Suppl 12):1955–1994 Dickman PW, Hakulinen T, Luostarinen T, Pukkala E et al (1999) Survival of cancer patients in Finland 1955–1994. Acta Oncol 38(Suppl 12):1955–1994
Metadaten
Titel
Dual effect of short interval between first and second birth on ductal breast cancer risk in Finland
verfasst von
A. Kauppila
P. Kyyrönen
M. Lehtinen
E. Pukkala
Publikationsdatum
01.01.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 1/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9868-7

Weitere Artikel der Ausgabe 1/2012

Cancer Causes & Control 1/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.